Pletal Alternatives Compared
Pletal | Cilostazol | Pentoxifylline |
|
---|
Pletal (cilostazol) | Cilostazol | Pentoxifylline |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Intermittent Claudication. Pletal may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Intermittent Claudication. cilostazol may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Intermittent Claudication. pentoxifylline may also be used for purposes not listed in this medication guide. |
||||||||||||||||
More about Pletal (cilostazol) | More about Cilostazol | More about Pentoxifylline | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Pletal has an average rating of 7.2 out of 10 from a total of 5 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 20% reported a negative effect. |
Cilostazol has an average rating of 6.5 out of 10 from a total of 15 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 27% reported a negative effect. |
Pentoxifylline has an average rating of 8.4 out of 10 from a total of 5 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Pletal side effects in more detail. |
See also: cilostazol side effects in more detail. |
See also: pentoxifylline side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
Lower cost generic approved |
Lower cost generic |
Lower cost generic |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all cilostazol prices |
View all pentoxifylline prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
13 hours |
13 hours |
2 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 459 drugs are known to interact with Pletal:
|
A total of 459 drugs are known to interact with cilostazol:
|
A total of 255 drugs are known to interact with pentoxifylline:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
January 15, 1999 |
January 15, 1999 |
August 30, 1984 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.